| ADCY2 |
adenylate cyclase 2 (brain) |
1,8E-02 |
4,9E-02 |
6,3E-03 |
| ADCY9 |
adenylate cyclase 9 |
1,2E-02 |
4,4E-02 |
4,1E-02 |
| ADRA1A |
adrenoceptor alpha 1A |
1,4E-02 |
1,1E-02 |
3,8E-02 |
| ATP2B2 |
ATPase, Ca++ transporting, plasma membrane 2 |
8,3E-03 |
2,2E-02 |
4,4E-02 |
| CACNA1A |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
3,0E-02 |
3,9E-02 |
4,2E-02 |
| CACNA1B |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
4,2E-02 |
1,8E-02 |
4,7E-02 |
| CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
7,8E-03 |
1,3E-02 |
2,2E-02 |
| CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
7,6E-03 |
1,2E-02 |
2,1E-02 |
| CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
8,7E-03 |
4,1E-02 |
3,1E-02 |
| CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
4,1E-02 |
2,4E-02 |
2,3E-02 |
| CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
2,5E-02 |
5,0E-02 |
3,4E-02 |
| CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
6,3E-03 |
4,8E-02 |
4,6E-02 |
| CHRM2 |
cholinergic receptor, muscarinic 2 |
2,0E-02 |
4,7E-02 |
2,3E-02 |
| CHRM3 |
cholinergic receptor, muscarinic 3 |
1,9E-02 |
4,0E-02 |
4,1E-02 |
| EGFR |
epidermal growth factor receptor |
5,0E-03 |
3,5E-02 |
3,7E-02 |
| ERBB4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
2,3E-02 |
1,3E-02 |
1,7E-02 |
| GNA14 |
guanine nucleotide binding protein (G protein), alpha 14 |
3,9E-02 |
4,9E-02 |
3,7E-02 |
| GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
7,9E-04 |
3,5E-03 |
2,7E-02 |
| GRM1 |
glutamate receptor, metabotropic 1 |
5,0E-02 |
3,7E-02 |
1,9E-02 |
| GRM5 |
glutamate receptor, metabotropic 5 |
2,3E-02 |
4,7E-02 |
1,6E-02 |
| ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
3,5E-02 |
2,2E-02 |
2,1E-02 |
| ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
1,9E-02 |
4,2E-02 |
3,2E-02 |
| LHCGR |
luteinizing hormone/choriogonadotropin receptor |
1,6E-02 |
3,7E-02 |
3,9E-02 |
| NOS1 |
nitric oxide synthase 1 (neuronal) |
3,0E-02 |
1,6E-02 |
4,7E-02 |
| P2RX7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
4,7E-02 |
3,4E-02 |
4,0E-02 |
| PDE1A |
phosphodiesterase 1A, calmodulin-dependent |
4,5E-02 |
2,7E-02 |
3,3E-02 |
| PDE1C |
phosphodiesterase 1C, calmodulin-dependent 70kDa |
6,4E-03 |
4,2E-02 |
4,3E-02 |
| PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
2,1E-03 |
4,6E-02 |
1,7E-02 |
| PLCB4 |
phospholipase C, beta 4 |
4,4E-02 |
3,7E-02 |
1,3E-03 |
| PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
2,2E-02 |
1,2E-02 |
4,0E-02 |
| PLCZ1 |
phospholipase C, zeta 1 |
4,5E-02 |
2,7E-02 |
3,7E-02 |
| PRKCA |
protein kinase C, alpha |
3,6E-02 |
3,5E-02 |
1,4E-02 |
| PRKCB |
protein kinase C, beta |
4,4E-02 |
2,2E-03 |
3,3E-02 |
| PTGER3 |
prostaglandin E receptor 3 (subtype EP3) |
3,3E-02 |
3,3E-02 |
3,6E-02 |
| RYR1 |
ryanodine receptor 1 (skeletal) |
4,7E-02 |
3,1E-02 |
1,8E-02 |
| RYR2 |
ryanodine receptor 2 (cardiac) |
3,9E-02 |
3,2E-02 |
1,6E-02 |
| RYR3 |
ryanodine receptor 3 |
2,0E-02 |
2,9E-02 |
4,8E-02 |
| SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
2,1E-02 |
4,5E-02 |
2,7E-02 |
| TACR1 |
tachykinin receptor 1 |
5,4E-03 |
3,1E-02 |
1,5E-02 |
